Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStatPro Regulatory News (SOG)

  • There is currently no data for SOG

Director/PDMR Shareholding

30 Mar 2011 16:25

RNS Number : 9483D
Statpro Group PLC
30 March 2011
 



 

 

For immediate release 30 March 2011

 

STATPRO GROUP PLC

("StatPro" or the "Group")

 

Directors' dealings

Exercise and Net settlement of Share Options

 

Grant of options

StatPro Group plc (AIM:SOG), the AIM listed provider of portfolio analytics and data solutions for the global asset management industry, today announces the grant of share options over a total of 600,000 ordinary shares of 1p each in the Company ("Ordinary Shares") to directors and senior employees in the Group.

 

The options are exercisable at 130p per share being a premium of 10% over the closing mid-market share price of 118p per Ordinary Share on 29 March 2011. Exercise of the options is conditional upon the satisfaction of performance conditions. The options will not be exercisable unless the share price equals or exceeds 145p per share for a period of at least twenty consecutive trading days and specified targets of growth in earnings per share are met. The share options are exercisable at any time between 29 March 2014 and 29 March 2018 being a period of between three years and seven years from the date of grant, subject to the satisfaction of the performance conditions.

 

The grants of options include grants to StatPro's executive directors over the following numbers of shares:

 

Justin Wheatley, Chief Executive 35,000

Andrew Fabian, Finance Director 35,000

 

Exercise and Net settlement of Share Options

Following the receipt by the Company of applications relating to the exercise of options over 140,583 shares at exercise prices of 60p or 61p under Company share option schemes, the Company has opted to net settle 74,500 options by cash settlement in order to reduce the impact of dilution. The net settlement value was determined by the Board as 118p per ordinary share. As a result, cash amounting to a total of approximately £43,000 including option tax liability has been paid and 66,083 shares have been issued. Application has been made for the admission to AIM of 66,083 new Ordinary Shares. It is expected that dealings will commence on 5 April 2011. These shares will rank pari passu with the Group's existing issued Ordinary Shares.

 

Within this total, Andrew Fabian, Finance Director, exercised on 29 March 2011 35,000 options at 60p per share and subsequently sold 35,000 shares today at 116.4p per share from his SIPP resulting in no beneficial change to his holdings.

 

Other director dealings

The Company was informed today that on 29 March 2011 Mark Adorian, Non-Executive Director, purchased 120,000 Ordinary Shares and his wife sold 120,000 Ordinary Shares at 118p per share resulting in no beneficial change to his holdings.

 

The Company was informed today that Charles Fairbairn, Non-Executive Director, purchased 24,400 Ordinary Shares today in his SIPP at 117.5p per share and sold today 24,400 Ordinary Shares in his own name at 117.5p per share resulting in no beneficial change to his holdings.

 

Following these allocations and transactions Justin Wheatley is interested in 7,159,367 Ordinary Shares representing approximately 11.78% of the Company's issued ordinary share capital and options over 1,170,000 Ordinary Shares. Andrew Fabian is interested in 207,795 Ordinary Shares representing approximately 0.34% of the Company's issued Ordinary Share capital and options over 182,000 Ordinary Shares. Mark Adorian is interested in 2,520,698 Ordinary Shares representing approximately 4.15% of the Company's issued Ordinary Share capital. Charles Fairbairn is interested in 779,834 Ordinary Shares representing approximately 1.28% of the Company's issued Ordinary Share capital.

 

Voting rights

Following Admission, the Company's enlarged issued share capital will comprise 60,793,315 Ordinary Shares with voting rights and the Company holds 225,000 shares in treasury. This figure of 60,793,315 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

- Ends -

 

For further information, please contact:

 

StatPro Group plc

www.statpro.com

Justin Wheatley, Chief Executive

020 8410 9876

Andrew Fabian, Finance Director

 

Cenkos Securities

Ken Fleming (NOMAD)

0131 220 6939

Jon Fitzpatrick (NOMAD)

0207 397 8900

Julian Morse (Broker)

020 7397 1931

Threadneedle Communications

Caroline Evans-Jones/ Tom Moriarty/ Hilary Millar

 

020 7653 9850

 

About StatPro

StatPro is a leading provider of portfolio analytics and data solutions for the global asset management industry. The Company sells a SaaS-based Analytics and Data platform on a rental basis to investment management companies allowing them to analyse portfolio performance, attribution, risk and GIPS® compliance. StatPro also provides market data and valuation feeds including a Complex Asset Pricing service.

StatPro has grown its recurring revenue from less than £1 million in 1999 to £29 million at end December 2010 and currently enjoys a renewal rate of approximately 92%. StatPro floated on the London Stock Exchange in May 2000 and transferred its listing in June 2003 to AIM. The Company has operations in Europe, North America, South Africa and Australia, with approximately 79% of recurring revenues being generated outside the UK.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSDUFISFFSEFD
Date   Source Headline
20th Sep 20197:00 amRNSRecommended Cash Offer
7th Aug 20191:29 pmRNSDirector/PDMR dealing
31st Jul 20197:00 amRNSInterim results
17th Jul 20195:32 pmRNSTotal Voting Rights
2nd Jul 201911:00 amRNSNotice of Results
1st Jul 20191:25 pmRNSCompletion of ESG research and index business deal
1st Jul 20197:00 amRNS£1.5m Revolution conversion
26th Jun 20193:58 pmRNSDirector/PDMR Shareholding
24th Jun 20197:00 amRNSJ.P. Morgan partners with StatPro
12th Jun 20197:00 amRNSStatPro acquires ESG research and index business
23rd May 20192:25 pmRNSResult of AGM / Appointment of Company Secretary
23rd May 20197:00 amRNSAGM statement and trading update
20th May 20197:00 amRNSTop 20 Fund Administrator 3 yr contract extension
10th May 20197:00 amRNSEU investment manager group signs EUR1.2m contract
8th May 20194:36 pmRNSSiSoft update
18th Apr 201912:51 pmRNSPosting of Annual Report and Notice of AGM
16th Apr 20197:00 amRNSFinancing facilities increase and extension
3rd Apr 20197:00 amRNS$1.2m contract extension for Revolution
29th Mar 20194:20 pmRNSDirector/PDMR Shareholding
18th Mar 201911:09 amRNSIssue of Equity and Director/PDMR dealing
13th Mar 20197:00 amRNSSolid growth in revenue and profit
4th Feb 201910:00 amRNSNotice of Results
23rd Jan 20197:00 amRNSYear end trading update
15th Jan 20197:00 amRNSContract with large US asset service provider
10th Jan 20197:00 amRNSRevolution contract win
8th Jan 20197:00 amRNSLarge UK Investment Manager signs £2.35m contract
19th Dec 20187:00 amRNSEuropean insurance group signs £1.125m contract
17th Dec 20185:53 pmRNSHolding(s) in Company
14th Dec 20183:58 pmRNSDirector/PDMR Shareholding
7th Dec 20189:55 amRNSHolding(s) in Company
7th Dec 20189:55 amRNSHolding(s) in Company
28th Nov 20187:00 amRNSCapital Markets Day
25th Oct 20187:00 amRNSQ3 trading update
23rd Oct 20187:00 amRNSSouth African financial institution contract
6th Sep 20189:45 amRNSNotification of major holdings
2nd Aug 201812:48 pmRNSDirector/PDMR dealing
1st Aug 20187:00 amRNSInterim results
11th Jul 20189:00 amRNSNotice of Results
2nd Jul 20187:00 amRNSStatPro acquires regulatory risk services bureau
28th Jun 20187:00 amRNSDivisional CEO of Source: StatPro appointed
22nd Jun 20183:58 pmRNSAdditional Listing/PDMR Shareholding
6th Jun 20188:00 amRNSBroadridge partners with StatPro
24th May 20181:53 pmRNSResult of AGM
24th May 20189:16 amRNSHolding(s) in Company
24th May 20187:00 amRNSAGM statement and trading update
23rd May 20184:55 pmRNSHolding(s) in Company
23rd May 20184:55 pmRNSHolding(s) in Company
21st May 20182:22 pmRNSDirector/PDMR dealing
17th May 20184:47 pmRNSResult of secondary placing of existing shares
17th May 20183:49 pmRNSProposed secondary placing of existing shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.